Titelia

Holdings of Redmile Group, LLC

30 declared positions · as of Mar 31, 2026

Original filing · Ten largest lines: 85.2 % of the equity sleeve

Sector breakdown

  • Unattributed 100.0 %

Titelia classification, company by company. The unattributed share stays visible.

Currency breakdown

  • USD 100.0 %

The quoted currency of each line, as declared.

Country breakdown

  • US 98.4 %
  • GB 0.8 %
  • FR 0.7 %
  • BE 0.1 %

Shares computed on the equity sleeve.

CountryLinesValueShare
US271.4B $98.36 %
GB111.4M $0.80 %
FR110.3M $0.72 %
BE11.6M $0.12 %

Positions

CompanySharesValueWeight
Scholar Rock Holding Corp 9,066,621445.7M $
Krystal Biotech Inc 673,505174M $
Stoke Therapeutics Inc 4,164,120135.6M $
Immunome Inc 5,558,885121.6M $
Nurix Therapeutics Inc 7,732,808119.9M $
Annexon Inc 14,549,76880.6M $
REGENXBIO Inc 4,368,80436.6M $
Shattuck Labs Inc 5,539,72435.6M $
Beam Therapeutics Inc 1,237,65929.5M $
Neurogene Inc 1,459,59929.4M $
Cogent Biosciences Inc 688,03626.5M $
Absci Corp 8,253,31624.8M $
Ideaya Biosciences Inc 521,11717.4M $
ALX Oncology Holdings Inc 7,964,18816M $
Fate Therapeutics Inc 12,872,94615.4M $
Solid Biosciences Inc 2,011,89514.5M $
Nuvation Bio Inc 3,153,25613.5M $
Zymeworks Inc 491,65412.3M $
Silence Therapeutics PLC 2,164,77711.4M $
DBV Technologies SA 491,34010.3M $
BioMarin Pharmaceutical Inc 173,8599.8M $
Celldex Therapeutics Inc 261,5088.3M $
Ceribell Inc 386,7867.1M $
Prime Medicine Inc 1,590,8325.5M $
ORIC Pharmaceuticals Inc 415,7105.3M $
Ardelyx Inc 733,3504.4M $
Invivyd Inc 2,648,6593.4M $
Atara Biotherapeutics Inc 441,7012.1M $
AGOMAB THERAPEUTICS SA 156,2501.6M $
Pliant Therapeutics Inc 772,126972.9K $